Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2018, Article ID 1371425, 10 pages
https://doi.org/10.1155/2018/1371425
Research Article

Association of Maternal and Fetal Single-Nucleotide Polymorphisms in Metalloproteinase (MMP1, MMP2, MMP3, and MMP9) Genes with Preeclampsia

1Department of Medical Biotechnology, Medical University of Lodz, Łódź, Poland
2Department of Obstetrics, Perinatology and Gynecology, Polish Mother’s Memorial Hospital Research Institute, Łódź, Poland
3Department of Obstetrics and Perinatology, University Hospital in Kraków, Kraków, Poland
4Department of Genetics, Polish Mother’s Memorial Hospital-Research Institute, Łódź, Poland
5Department of Microelectronics and Computer Science, Lodz University of Technology, Łódź, Poland

Correspondence should be addressed to Agata Sakowicz; moc.liamg@zciwokas.ataga

Received 23 August 2017; Revised 30 October 2017; Accepted 11 January 2018; Published 18 February 2018

Academic Editor: Yi-Chia Huang

Copyright © 2018 Agata Sakowicz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Kallela, T. Jaaskelainen, E. Kortelainen et al., “The diagnosis of pre-eclampsia using two revised classifications in the Finnish Pre-eclampsia Consortium (FINNPEC) cohort,” BMC Pregnancy & Childbirth, vol. 16, p. 221, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy, “Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy,” Obstetrics & Gynecology, vol. 122, no. 5, pp. 1122–1131, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. A. L. Tranquilli, G. Dekker, L. Magee et al., “The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP,” Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health, vol. 4, no. 2, pp. 97–104, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Rahardjo, E. Widjajanto, H. Sujuti, and K. Keman, “Different levels of IL-1α, IL-6, TNF-α, NF-κB and PPAR-γ in monocyte cultures exposed by plasma preeclampsia and normotensive pregnancy,” Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health, vol. 4, no. 3, pp. 187–193, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. C. J. Lockwood, M. Basar, U. A. Kayisli et al., “Interferon-γ protects first-trimester decidual cells against aberrant matrix metalloproteinases 1, 3, and 9 expression in preeclampsia,” The American Journal of Pathology, vol. 184, no. 9, pp. 2549–2559, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Chappell and L. Morgan, “Searching for genetic clues to the causes of pre-eclampsia,” Clinical Science, vol. 110, no. 4, pp. 443–458, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Cnattingius, M. Reilly, Y. Pawitan, and P. Lichtenstein, “Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study,” American Journal of Medical Genetics Part A, vol. 130A, no. 4, pp. 365–371, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Skjaerven, L. J. Vatten, A. J. Wilcox, T. Rønning, L. M. Irgens, and R. T. Lie, “Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort,” BMJ, vol. 331, no. 7521, pp. 877–870, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Laivuori, “Genetic aspects of preeclampsia,” Frontiers in Bioscience, vol. 12, no. 1, pp. 2372–2382, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Y. Zhu, Z. J. Pang, and Y. H. Yu, “Regulation of trophoblast invasion: the role of matrix metalloproteinases,” Reviews in Obstetrics & Gynecology, vol. 5, no. 3-4, pp. e137–e143, 2012. View at Google Scholar
  11. O. M. Omran, M. Shokry, H. Ismail, G. Omar, and M. Rezk, “Expression of matrix metalloproteinases 2 and 9 in human trophoblasts of normal and preeclamptic placentas,” International Journal of Health Sciences, vol. 5, Supplement 1, no. 2, pp. 21–23, 2011. View at Google Scholar
  12. F. Reister, J. C. Kingdom, P. Ruck et al., “Altered protease expression by periarterial trophoblast cells in severe early-onset preeclampsia with IUGR,” Journal of Perinatal Medicine, vol. 34, no. 4, pp. 272–279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Fanjul-Fernandez, A. R. Folgueras, S. Cabrera, and C. López-Otín, “Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1803, no. 1, pp. 3–19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Yan and D. D. Boyd, “Regulation of matrix metalloproteinase gene expression,” Journal of Cellular Physiology, vol. 211, no. 1, pp. 19–26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Sole, E. Guino, J. Valls, R. Iniesta, and V. Moreno, “SNPStats: a web tool for the analysis of association studies,” Bioinformatics, vol. 22, no. 15, pp. 1928-1929, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Y. Lou, G. B. Chen, L. Yan et al., “A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence,” The American Journal of Human Genetics, vol. 80, no. 6, pp. 1125–1137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. G. B. Chen, Y. Xu, H. M. Xu, M. D. Li, J. Zhu, and X. Y. Lou, “Practical and theoretical considerations in study design for detecting gene-gene interactions using MDR and GMDR approaches,” PLoS One, vol. 6, no. 2, article e16981, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. C. C. Yeh, K. C. Chao, and S. J. Huang, “Innate immunity, decidual cells, and preeclampsia,” Reproductive Sciences, vol. 20, no. 4, pp. 339–353, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Zhang, S. Ye, S. M. Herrmann et al., “Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis,” Circulation, vol. 99, no. 14, pp. 1788–1794, 1999. View at Publisher · View at Google Scholar
  20. C. J. Lockwood, C. Oner, Y. H. Uz et al., “Matrix metalloproteinase 9 (MMP9) expression in preeclamptic decidua and MMP9 induction by tumor necrosis factor alpha and interleukin 1 beta in human first trimester decidual cells,” Biology of Reproduction, vol. 78, no. 6, pp. 1064–1072, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Galewska, L. Romanowicz, S. Jaworski, and E. Bańkowski, “Gelatinase matrix metalloproteinase (MMP)-2 and MMP-9 of the umbilical cord blood in preeclampsia,” Clinical Chemistry and Laboratory Medicine, vol. 46, no. 4, pp. 517–522, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. L. C. Poon, E. Nekrasova, P. Anastassopoulos, P. Livanos, and K. H. Nicolaides, “First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome,” Prenatal Diagnosis, vol. 29, no. 6, pp. 553–559, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Coolman, M. M. de, W. L. Van Heerde et al., “Matrix metalloproteinase-9 gene -1562C/T polymorphism mitigates preeclampsia,” Placenta, vol. 28, no. 7, pp. 709–713, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. A. C. Palei, V. C. Sandrim, G. Duarte, R. C. Cavalli, R. F. Gerlach, and J. E. Tanus-Santos, “Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension,” Clinica Chimica Acta, vol. 411, no. 11-12, pp. 874–877, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. S. J. Price, D. R. Greaves, and H. Watkins, “Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation,” Journal of Biological Chemistry, vol. 276, no. 10, pp. 7549–7558, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Zhou, C. Yu, X. Miao et al., “Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility,” Carcinogenesis, vol. 26, no. 6, pp. 1117–1121, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. J. E. Myers, S. J. Merchant, M. Macleod, G. J. Mires, P. N. Baker, and S. T. Davidge, “MMP-2 levels are elevated in the plasma of women who subsequently develop preeclampsia,” Hypertension in Pregnancy, vol. 24, no. 2, pp. 103–115, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. A. C. Palei, V. C. Sandrim, L. M. Amaral et al., “Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy,” Experimental and Molecular Pathology, vol. 92, no. 2, pp. 217–221, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. D. P. Leonardo, D. M. Albuquerque, C. Lanaro et al., “Association of nitric oxide synthase and matrix metalloprotease single nucleotide polymorphisms with preeclampsia and its complications,” PLoS One, vol. 10, no. 8, article e0136693, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. J. L. Rutter, T. I. Mitchell, G. Buttice et al., “A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription,” Cancer Research, vol. 58, no. 23, pp. 5321–5325, 1998. View at Google Scholar
  31. M. Cohen, P. Ribaux, M. Epiney, and O. Irion, “Expression of metalloproteinases 1, 2, 7, 9, and 12 in human cytotrophoblastic cells from normal and preeclamptic placentas,” Neuro Endocrinology Letters, vol. 33, no. 4, pp. 406–411, 2012. View at Google Scholar
  32. C. L. Deng, S. T. Ling, X. Q. Liu, Y. J. Zhao, and Y. F. Lv, “Decreased expression of matrix metalloproteinase-1 in the maternal umbilical serum, trophoblasts and decidua leads to preeclampsia,” Experimental and Therapeutic Medicine, vol. 9, no. 3, pp. 992–998, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Jurajda, K. Kankova, J. Muzik et al., “Lack of an association of a single nucleotide polymorphism in the promoter of the matrix metalloproteinase-1 gene in Czech women with pregnancy-induced hypertension,” Gynecologic and Obstetric Investigation, vol. 52, no. 2, pp. 124–127, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. M. S. Kim, J. H. Yu, M. Y. Lee et al., “Differential expression of extracellular matrix and adhesion molecules in fetal-origin amniotic epithelial cells of preeclamptic pregnancy,” PLoS One, vol. 11, no. 5, article e0156038, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Faul, E. Erdfelder, A. G. Lang, and A. Buchner, “GPower 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences,” Behavior Research Methods, vol. 39, no. 2, pp. 175–191, 2007. View at Publisher · View at Google Scholar
  36. F. Faul, E. Erdfelder, A. Buchner, and A. G. Lang, “Statistical power analyses using GPower 3.1: tests for correlation and regression analyses,” Behavior Research Methods, vol. 41, no. 4, pp. 1149–1160, 2009. View at Publisher · View at Google Scholar · View at Scopus